Reimbursed Care Access in Belize

Currently classified as a strictly controlled substance under Belize’s Misuse of Drugs Act (psilocin is explicitly named in the Act’s schedule), with criminal penalties for unauthorized possession, supply or production and no authorized medical reimbursement or licensed therapeutic program outside of approved research under the Act. The statute contains broad scheduling language that captures psilocin/psilocybin and related derivatives, meaning there is no routine clinical or reimbursed medical access to psilocybin in Belize. #

Currently classified as a strictly controlled substance under national drug scheduling laws in Belize, with no authorized medical use outside of approved clinical research and no public reimbursement for MDMA‑assisted therapy. Multiple legal summaries and country drug‑law reviews list MDMA/’methylenedioxy’ amphetamine compounds as falling under Belize’s controlled‑substances regime and subject to criminal penalties. # #

Esketamine (Spravato) is not listed on Belize public formularies and there is no evidence of national registration or public reimbursement for esketamine‑based treatment in Belize; consequently it is not available as a reimbursed psychiatric therapy in routine practice. By contrast, ketamine (racemic) is included on Belize’s national formulary as an injectable anesthetic, indicating medical (procedural/anesthetic) availability but not an approved, reimbursed indication for formal esketamine psychiatric programs. Regulatory/registration searches for Spravato do not return Belize registry entries; local registration would be required before any reimbursed esketamine program could operate. #

Ketamine (injection) is listed on Belize’s National Drug Formulary for use as an anesthetic, demonstrating licensed medical availability in public health settings; however, there is no established, publicly reimbursed ketamine‑for‑depression program or national reimbursement policy for off‑label psychiatric ketamine infusion clinics referenced in national regulations. Use as an anesthetic follows standard procurement/health‑system formularies and would be reimbursed per existing public procurement and service rules, but psychiatric (off‑label) ketamine provision would generally be private/out‑of‑pocket or subject to individual institutional policies rather than a nationally reimbursed mental‑health therapy. #

Currently classified as a strictly controlled substance under Belize’s Misuse of Drugs Act—N,N‑Dimethyltryptamine (DMT) and related tryptamine compounds are listed or captured by the Act’s scheduling language—there is no authorized medical use or reimbursement outside of approved clinical research. The Act also contains broad clauses covering stereoisomers, salts and structurally derived tryptamine substances, which encompasses naturally occurring preparations (e.g., DMT‑containing plant materials) for legal purposes. #

Currently classified as a strictly controlled substance under Belize’s Misuse of Drugs Act via named tryptamine listings and the Act’s broad catch‑all provisions for tryptamine derivatives; there is no authorized medical use or reimbursement for 5‑MeO‑DMT outside of approved clinical research. Possession, supply or distribution outside lawful research/authorization is criminalized. #

Currently classified as a strictly controlled substance under national drug scheduling laws (ibogaine and related controlled compounds are not available for authorized medical treatment or reimbursement in Belize) and therefore have no authorized medical use outside of approved clinical research. The Misuse of Drugs Act’s schedules and catch‑all derivative language apply to complex psychoactive alkaloids and make unauthorized use a criminal offence. #

Because the Misuse of Drugs Act lists DMT and contains broad scheduling language capturing tryptamine‑containing preparations, ayahuasca (which contains DMT) is effectively controlled under Belizean law and has no authorized medical reimbursement or legal recreational status—any use outside specifically authorized research/clinical exemptions would be subject to criminal penalties. There are occasional informal/retreat reports of ayahuasca ceremonies in the region, but those do not reflect lawful, reimbursed medical programs. #

Mescaline is explicitly named in the Misuse of Drugs Act schedule, making it a controlled substance in Belize with no authorized medical reimbursement or routine medical use outside of approved clinical research. Unauthorized possession, supply or manufacture is criminalized. #

Any phenethylamine derivatives and many substituted phenethylamines are captured by the Misuse of Drugs Act’s scheduling and catch‑all provisions; consequently, 2C‑series compounds are covered by the controlled substances regime and have no authorized medical use or reimbursement outside approved research. Possession, supply or distribution is criminalized under the Act. #